Searched for
DIABETES PILL
'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Kim Kardashian reveals she takes 35 supplements a day, opens up about ‘pill fatigue’: What it is and how it can affect your healthReality star Kim Kardashian revealed she takes nearly 35 supplements daily, leading to "pill fatigue." She humorously wished for an IV drip...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- Novo rebrands diabetes pill as Ozempic to tap blockbuster nameNovo Nordisk is relaunching a diabetes tablet as Ozempic in the United States. This move aims to boost sales by using the strong brand reco...
- US Stocks: Eli Lilly raises annual forecasts as GLP-1 drugs fuel growthEli Lilly raised its annual profit and revenue forecasts and posted better-than-expected first quarter on Thursday, on steady demand for it...
- Woman felt strange sensation in legs for 6 months, pain was worse at night while lying down. Hyderabad Neurologist reveals what went wrongDR Sudhir Kumar, a Hyderabad-based neurologist at Apollo Hospitals, revealed a case in which a woman experienced strange pain in her legs f...
- Different packaging, typos expose fake Mounjaro racketGurugram authorities uncovered a counterfeit Mounjaro operation. Police seized fake diabetes and weight loss injections valued at ₹70 lakh....
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
- Lilly's weight-loss pill shows better blood sugar control in late-stage trialsEli Lilly's experimental oral weight-loss drug, orforglipron, demonstrated superior blood sugar control in diabetic patients across two lat...
- Lilly pill cuts body weight by 10.5% in patients with type 2 diabetesEli Lilly's new pill shows promise. The drug helped people with diabetes lose weight in trials. The pill, orforglipron, led to a 10.5% weig...
- Shedding weight may no longer be a prickly issue as Eli Lilly’s weight-loss pill moves closer to launchEli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the US. Participant...
- Say goodbye to needle pricks! A daily pill may be cure to world's obesity problemNovo Nordisk's weight-loss drug, Wegovy, which has so far only been available as an injection, may soon come in pill form. Clinical trials ...
- Novo Nordisk launches anti-diabetes pill semaglutide in IndiaNovo Nordisk, the Danish drug maker on Thursday announced the launch of oral semaglutide in India for treatment of type 2 diabetes.
- MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battleEarlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.
- Type 2 diabetes can now be reversed, thanks to the less invasive 'surgery in a pill'Scientists have developed an effective treatment for reversing diabetes that can offer the same benefits as surgery.
Load More
